FDA Okays Breo Ellipta for Asthma in Adults – Medscape


Medscape

FDA Okays Breo Ellipta for Asthma in Adults
Medscape
The US Food and Drug Administration (FDA) has approved the combination of fluticasone furoate/vilanterol (Breo Ellipta, GlaxoSmithKline/Theravance) for the once-daily treatment of asthma in adults aged 18 years and older. Fluticasone furoate (FF) is an …
FDA approves Glaxo, Theravance's Breo Ellipta asthma drugReuters
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the USMarketWatch
Science Recorder
all 48 news articles »

View full post on asthma – Google News

FDA okays generic Singulair for asthma treatment – The Capitol Column


The Capitol Column

FDA okays generic Singulair for asthma treatment
The Capitol Column
The FDA announced Friday that it has approved the production of generic versions of Singulair, a drug used for the treatment of asthma and allergies. The patent on Singulair, or montelukast sodium, was held by Merck, and expired on Aug. 3, 2012. The
FDA Approves Generic Versions Of Singulair To Treat Asthma, AllergiesRTT News
FDA OKs generic SingulairChicago Tribune
Generic Singulair ApprovedWebMD
Globes –MedPage Today
all 37 news articles »

View full post on asthma – Google News